AI, AlphaFold & drug discovery. With Max Jaderberg, Director of Machine Learning at Isomorphic Labs- A Google DeepMind sister company

Max Jaderberg, Director of Machine learning at Isomorphic labs, shares the Isomorphic approach to drug discovery in one of their first interviews as they emerge from shadow mode. In 2020 Google DeepMind made history when they took on the grand challenge of biology- the protein folding problem- with their algorithm AlphaFold2.  Their success prompted the creation of a sister company, Isomorphic Labs. Our conversation topics include:   - The concept of “Digital Biology”- How AI can be used model the biological world  - Bottlenecks in the drug discovery process and how AI could circumvent them - How AI may unlock 'undraggable targets' to find treatments for incurable diseases  Links: Isomorphic labs website: https://www.isomorphiclabs.com/ AlphaMissence: https://www.deepmind.com/blog/alphamissense-catalogue-of-genetic-mutations-to-help-pinpoint-the-cause-of-diseases

There are no comments yet.

Please log in to write the first comment.